Selective Serotonin Reuptake Inhibitors and Suicidality in Juveniles: Review of the Evidence and Implications for Clinical Practice
Authors:
- Joseph M. ReyJRJoseph M. Rey
- Andrés MartinAMAndrés Martin
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Child and Adolescent Psychiatric Clinics of North America
- Vol. 15 (1) , 221-237
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Food and Drug Administration’s Deliberations on Antidepressant Use in Pediatric PatientsPediatrics, 2005
- Rethinking childhood depressionBMJ, 2004
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished dataThe Lancet, 2004
- FDA advisory panel calls for suicide warnings over new antidepressantssBMJ, 2004
- Antidepressant Treatment and Risk of Suicide Attempt by Adolescents with Major Depressive DisorderCNS Drugs, 2004
- SSRIs ASSOCIATED WITH BEHAVIORAL ACTIVATION AND SUICIDAL IDEATIONJournal of the American Academy of Child & Adolescent Psychiatry, 2001
- Pharmacology of the Selective Serotonin Reuptake Inhibitors in Children and AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 1997
- Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.BMJ, 1991
- Emergence of Self-Destructive Phenomena in Children and Adolescents during Fluoxetine TreatmentJournal of the American Academy of Child & Adolescent Psychiatry, 1991
- Emergence of intense suicidal preoccupation during fluoxetine treatmentAmerican Journal of Psychiatry, 1990